Financials
| Div Yield |
2.4% |
2.1% |
| Div Cover |
2.32 |
n/a |
| Op Mrgn |
1.2% |
n/a |
| ROCE |
19.7% |
|
| P/E |
194.33 |
35.04 |
| PEG |
4.33 |
2.26 |
| Pr/Revenue |
1.92 |
n/a |
| Pr/Book |
3.29 |
|
| Revenue |
3.0% |
n/a |
| PBT |
-3.7% |
n/a |
| EPS |
-5.2% |
62.4% |
| DPS |
-1.5% |
|
| 1 week |
6,145.42 |
-111.68 |
-1.82% |
| 1 month |
6,033.74 |
0.00 |
n/a |
| 3 months |
5,564.43 |
+469.31 |
+8.43% |
| 6 months |
5,402.83 |
+630.91 |
+11.68% |
| 1 year |
4,741.18 |
+1,292.56 |
+27.26% |
| GNS | 27-Feb-26 |
Buy |
Celia Baxter |
2,892.87p | 1,728 |
£49,988.71 |
| GSK | 20-Feb-26 |
Buy |
Hal Barron |
4,415.59p | 64 |
£2,825.98 |
| GSK | 20-Feb-26 |
Buy Dividends |
Hal Barron |
4,415.59p | 2,007,552 |
£88,645,348.67 |
| OXB |
654.00p |
+5.3% |
| GNS |
2,925.00p |
+3.0% |
| BT.A |
214.00p |
+2.9% |
| TRD |
305.00p |
+1.7% |
| QQ. |
507.50p |
+1.5% |
| XPP |
1,402.00p |
+1.2% |
| BA. |
2,142.00p |
+1.1% |
| GSK |
2,186.00p |
+0.9% |
| SN. |
1,361.00p |
+0.6% |
| CCC |
3,158.00p |
+0.5% |
| FLTR |
7,648.00p |
-15.7% |
| BVC |
13.80p |
-3.8% |
| NCC |
131.40p |
-3.8% |
| DIA |
290.00p |
-3.7% |
| RM. |
99.00p |
-2.0% |
| OXIG |
2,590.00p |
-1.3% |
| RSW |
4,290.00p |
-1.3% |
| SGE |
825.20p |
-1.2% |
| VOD |
114.20p |
-0.3% |
| APTD |
243.00p |
-0.0% |
Top of Page
You are here:
research